Oppenheimer raised the firm’s price target on Aramark to $39 from $36 and keeps an Outperform rating on the shares. The firm notes CEO John Zillmer was upbeat and suggested the company’s new business pipeline is still near record levels. Demand is solid across all regions and verticals, particularly B&I, Sports & Leisure, Corrections, and Healthcare. Pricing should continue to be a tailwind as inflation moderates and offsets any inflationary cost pressures, Oppenheimer adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARMK: